Peter Lin MD, CCFP
Director, Primary Care Initiatives, Canadian Heart Research Centre, North York, OntarioDr. Peter Lin, a primary care physician, is the Director of Primary Care Initiatives at the Canadian Heart Research Centre and has two busy family medicine practices in Toronto. For 7 years, he served as the medical director at the University of Toronto Scarborough Health & Wellness Centre. In 2011, he received a teaching award from the College of Family Physicians of Canada.
Dr. Lin has worked with KDIGO (Kidney Disease│Improving Global Outcomes) in an effort to help enhance care for patients with chronic kidney disease. He has been a contributing author to the Canadian Diabetes Guidelines and has served on the editorial board of Pri-Med Institute, which provides education for physicians.
Dr. Lin maintains an active lecture schedule, reflecting his varied medical interests, continuing his focus on bridging the chasm between research and clinical practice.
Disclosures
- Consultant (continuing medical education programs): AstraZeneca; Boehringer Ingelheim; Bayer; Eli Lilly; Amgen; Janssen; Merck; Pfizer; Sanofi; Abbott; HLS Therapeutics
Recent Contributions to PracticeUpdate:
- Benefits and Harms of Intensive Blood Pressure Treatment in Older Adults
- Guidelines for Treatment of Hypertension in Adults Aged 60 and Older
- Optimal Systolic Blood Pressure Target After SPRINT
- Statin Therapy as Primary Prevention in Exercising Adults
- Diagnosis Not Confirmed in One-Third of Adults With Physician-Diagnosed Asthma
- Use of Metformin in CKD, CHF, and CLD Associated With Reduced Mortality
- Genetics: Implications for Prevention and Management of Coronary Artery Disease
- Vitamin D Receptor Genotype, Vitamin D3 Supplementation, and Risk of Colorectal Adenomas
- PCSK9 Genetic Variants Associated With Increased Risk for Type 2 Diabetes
- PCSK9 and HMGCR Variants Are Associated With Cardiovascular Disease and Diabetes